OTCMKTS:BSGM
BioSig Technologies, Inc Stock News
$1.71
-0.0700 (-3.93%)
At Close: May 03, 2024
BioSig Technologies, Inc. to Present at the Jefferies Virtual Healthcare Conference
10:30am, Friday, 28'th May 2021
Westport, CT, May 28, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing platfo
BioSig Technologies, Inc. to Present at the Oppenheimer MedTech, Tools & Diagnostics Summit
09:15am, Friday, 21'st May 2021
Westport, CT, May 21, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing platfo
BioSig Technologies looking to unlock the future of bioelectronic medicine
12:32pm, Wednesday, 12'th May 2021
Using targeted electrical signals to harness the body's natural mechanisms to diagnose and treat a range of diseases Has commercialized its first product, a biomedical signal processing platform call
BioSig Sees Increased Case Volume from Expanding Base of Medical Centers Using Its Proprietary Signal Processing System
06:28pm, Tuesday, 04'th May 2021
The Company sees increased technology usage across its installed base and anticipates enrolling to at least 1500 cases by the end of 2021 44 physicians have conducted over 800 arrhythmia patient cases
BioSig Technologies increases patient case goal to 1,500 procedures by end of 2021
10:48am, Tuesday, 04'th May 2021
BioSig Technologies Inc (NASDAQ:BSGM), which is commercializing an innovative biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-card
BioSig Sees Increased Case Volume from Expanding Base of Medical Centers Using Its Proprietary Signal Processing System
09:15am, Tuesday, 04'th May 2021
Westport, CT, May 04, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signa
BioSig Technologies, Inc. (NASDAQ:BSGM) has announced that physicians at Mayo Clinic's campus in Phoenix, Arizona have started using the company's PURE EP System in patient cases treating cardiac arrh
BioSig's PURE EP(tm) System Evaluated with Patients at Mayo Clinic in Arizona
09:30am, Tuesday, 27'th Apr 2021
Westport, CT, April 27, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical sig
BioSig's Cardiac Signal Processing System Now Used At Mayo Clinic's Phoenix Campus
09:17am, Tuesday, 27'th Apr 2021
MedTech company BioSig Technologies, Inc.'s (NASDAQ: BSGM) first commercial product — the PURE EP system — is gaining traction with physicians and patients. What Happened: BioSig's PURE EP system
BioSig taps two regional directors to lead its commercial expansion across southeast and central regions of the US
12:42pm, Thursday, 15'th Apr 2021
BioSig Technologies Inc (NASDAQ:BSGM), which is commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals
BioSig Expands Commercial Team in Two Strategic Regions
11:45am, Thursday, 15'th Apr 2021
Two seasoned MedTech sales executives join the Company to lead regional rollouts of the PURE EP System (TM), an electrophysiology system for arrhythmia procedures Two seasoned MedTech sales executives
BioSig Technologies announces release of the PURE EP Software Version 4
10:50am, Wednesday, 14'th Apr 2021
BioSig Technologies, Inc. (NASDAQ:BSGM) has announced the release of the PURE EP Software Version 4. The latest release builds on the main system capabilities of the PURE EP while improving the overal
BioSig Launches Enhanced Signal Processing Capabilities for Advanced Cardiac Signal Analysis Through its Electrophysiology Platform
09:29am, Wednesday, 14'th Apr 2021
Westport, CT, April 14, 2021 (GLOBE NEWSWIRE) -- The latest release represents the most advanced software version of the PURE EPTM System, signal processing technology for treatments of irregular hear
BioSig Technologies completes enrollment in PURE EP 2.0 clinical trial
11:28am, Tuesday, 13'th Apr 2021
BioSig Technologies Inc (NASDAQ:BSGM) said it has completed enrollment in the PURE EP 2.0 clinical trial. The multi-center, prospective clinical trial was conducted at the Texas Cardiac Arrhythmia Ins
BioSig Completes Enrollment in the PURE EP 2.0 Clinical Study
09:32am, Tuesday, 13'th Apr 2021
Westport, CT, April 13, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal process
